New Venturetec reported earnings results for the six months ended March 31, 2015. For the six months, the company reported gain of USD 14,552,789 compared with a loss of USD 15,528,399 in the same period 2013/14. The net asset value per share increased from USD 9.93 to USD 12.85 which equals 29.4% during the reporting six month period.

The gain is mainly a result of the increase of the public traded share price of Osiris Therapeutics from USD 12.95 to USD 17.58, or 35.8% in the reporting period.